CLN2 Disorder
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A Safety, Tolerability, and Efficacy Study of BMN 190 in Pediatric Patients < 18 Years of Age With CLN2 Disease (NCT02678689) | BioMarin Pharmaceutical | 2016-01-22 |
| An Extension Study to Evaluate the Long-Term Efficacy and Safety of BMN 190 in Patients With CLN2 Disease (NCT02485899) | BioMarin Pharmaceutical | 2015-02-01 |
Track CLN2 Disorder automatically
Every clearance here is in the API, with alerts when new ones post.